Skip to content
ADRXADARx Pharmaceuticals, Inc.

Earnings

When ADARx Pharmaceuticals, Inc. reports, what it reported each quarter, and how the stock took the results.

6 quarters. Mar 31, 2025 to Sep 30, 2026. USD.

Quarter by quarter

Q3 2026$2.22M+42.6% vs Q3 2025

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 12, 2026 · after-hoursNov 12, 202643 d10-Q$2.22M+42.6%-$1.74—
Q2 2026Jun 30, 2026————————
Q1 2026Mar 31, 2026————————
FY 2025
Q3 2025Sep 30, 2025————$1.56M—-$1.85—
Q2 2025Jun 30, 2025————————
Q1 2025Mar 31, 2025————————

Source filings

10-QNov 12, 2026458444

Provenance

ProvenanceData status and checks

ADARx Pharmaceuticals, Inc. · CIK 1802369 · Engraved from SEC EDGAR